Presentations on drug-related deaths. by Rossini, Jane et al.
  
Welcome 
 
Dr Jane Rossini, Centre Deputy Director, North West, Public Health England 
Age-standardised drug misuse death rates 
(based on registration year), by region  
2 Presentation title - edit in Header and Footer 
Crude mortality rate (per million), deaths related to 
drug misuse, by NW LA, deaths registered between 
2006 and 2014 
 
3 Presentation title - edit in Header and Footer 
Today 
An opportunity to combine what we know nationally with the 
innovative work going on locally  
Determine some key messages and strategies that are relevant 
for the North West 
Develop an understanding of trends in drug related deaths, who 
is dying and under what circumstances in order to determine the 
most effective responses.   
You are the key drivers for understanding and preventing drug 
related deaths in your areas.  
You are the ambassadors with partners in the broader health, 
criminal justice and social care system where many of the 
solutions lie. 
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Drug-related deaths in England and the North West: 
latest data 
 
 
Martin White, Programme Manager, Evidence Application Team, Public Health 
England 
Data sources on drug-related deaths 
• ONS publish annual national statistics on registrations of drug-related 
deaths in England and Wales.  Latest bulletin is at 
http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarr
iages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/201
5-09-03 
• PHE receive row-level data from ONS and have published more detailed 
analyses focusing on deaths from drug misuse in England and cross-
referencing with treatment data. The most recent trend publication can be 
found at 
http://www.nta.nhs.uk/uploads/trendsdrugmisusedeaths1999to2014.pdf  
• The National Programme on Substance Abuse Deaths (NPSAD) is a 
special registry to which the majority of coroners in England report and can 
be found at http://www.sgul.ac.uk/research/population-health/our-
projects/national-programme-on-substance-abuse-deaths  
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Headline figures from recent ONS report 
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• ONS statistics report that North 
East and North West have highest 
rates among the nine regions in 
England 
 
• Both regions have significantly 
higher rates than the other seven 
regions in England 
 
• London has the lowest rate 
nationally, having fallen 
significantly over the time ONS 
have been reporting 
Regional variation 
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Registrations of drug misuse deaths, by region 
2013 rate 2014 rate % change 2013 to 2014
Regional variation – local data 
• ONS published figures at lower tier local authority level for the first time 
alongside their 2015 report – see 
http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarr
iages/deaths/datasets/drugmisusedeathsbylocalauthority 
• Due to small numbers annually at LA level, figures were pooled into three 
year bands up to 2012-14 – nevertheless there are still wide confidence 
limits and the figures require careful interpretation 
• Registration delays vary greatly between areas and this may also affect 
comparability between areas 
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Regional variation – local data 
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PHE analysis 
• PHE acquired extracts of drug-related death data from ONS and carried out 
more detailed analysis, including matching with drug treatment data from 
the National Drug Treatment Monitoring System (NDTMS) 
• Published two ‘Trends in drug misuse deaths in England’ reports: 
http://www.nta.nhs.uk/uploads/trendsdrugmisusedeaths1999to2014.pdf  
• Reported by year of death rather than year of registration 
• These analyses highlight long term trends and this access to the data 
allows us to investigate drug misuse deaths in more detail, including by 
region, as well as to estimate the effect of treatment 
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PHE analysis – impact of registration delays 
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PHE analysis – national – anti-depressants, 
sedatives and hypnotics 
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PHE analysis – national – stimulants and 
NPS 
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PHE analysis – regional – by substance 
*Note: May be subject to slight change as some deaths have yet to be registered. 
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Drug misuse deaths by substance, 2011-2013* 
North West National
PHE analysis – national – by age 
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*Note: May be subject to slight change as some deaths have yet to be registered. 
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Match of drug poisoning data to NDTMS data 
• Using an existing matching protocol, we were able to link opiate misuse 
deaths to NDTMS treatment data, covering the seven year period 2007-
2013 
• We then categorised opiate misuse deaths as follows: 
• In treatment 
• Within 6 months of successful completion 
• Between 6 and 12 months following a successful completion 
• Within 6 months of an unplanned exit from treatment 
• Between 6 and 12 months following an unplanned exit from treatment 
• More than 12 months from latest treatment contact 
• Never had treatment contact 
• Analysis was reported for each year from 2008 to 2013, to allow for a ‘run-
up’ 
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Match of drug poisoning data to NDTMS data 
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Match of drug poisoning data to NDTMS data 
• The analysis demonstrated that up to 2012 there was: 
• Similar proportion over time where the person had recently been in 
treatment (defined as within past year) 
• Slight increase in the proportion in treatment when they died 
• The majority still had not been in treatment in the period studied (i.e. 
since at least 2006) 
• By contrast, prevalence and treatment data suggest that the majority of 
opiate users have had recent treatment (see White et al, 2015* for a more 
detailed analysis) 
• However, the 2013 increase was slightly more marked among those with 
recent treatment than those without 
 
• *Full reference: White, M, Burton, R, Darke, S, Eastwood, B, Knight, J, Millar, T, Musto, V & Marsden, J (2015). 
Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use 
disorder in England. Addiction, 110, 1321-1329. 
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Match of drug poisoning data to NDTMS data 
• A low proportion (around 4%) had a successful completion in the past year 
– this has increased slightly over this period, although this is in the context 
of rising successful completion numbers 
• Analysis captures community treatment only.  Early indications from 
matching to prison treatment data over a limited time period seem to 
suggest around 6% had left prison treatment in the previous year, with 2% 
of the total having prison treatment without community treatment. 
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Stakeholder perceptions of take-home naloxone within 
prisons 
 
Arun Sondhi, Researcher, Therapeutic Solutions Ltd 
 Qualitative study aimed at understanding the 
barriers and challenges to implementation of take-
home naloxone (THN) within a prison setting 
 Describing staff and prisoner perceptions 
 Suggesting possible enhancements to service 
delivery 
 
Study Aims 
 Survey of prisoners receiving THN training 
(n=142)* 
Discussions with staff (n=17) and prisoners 
(n=26) 
Document analysis of local group meetings and 
performance data 
Study Methods 
 54% experienced an opiate-related overdose 
 79% overdose in presence of other drug users 
 38% taken by ambulance to hospital 
 73% witness someone else overdose 
Prisoner Survey 
 68% stated family/friends worried about 
prisoners overdosing on release 
 81% stated no or limited knowledge of naloxone 
High prisoner confidence following training in 
responding to a future OD episode  
 Follow-up training seen as important 
Prisoner Survey 
Negative and confused range of perceptions of 
THN amongst stakeholders 
Difficulties with the identification and 
engagement of eligible prisoners 
 Prison processes key 
Need senior staff engagement  
Themes Identified 
Name confusion (e.g. naltrexone) 
Word-of-mouth influences (“instant rattle”) 
 Fear of police contact whilst in possession of a 
kit 
Disconnect between harm reduction and 
abstinent objectives 
Negative and confused range of 
perceptions 
“Since I’ve come to this jail, everyone [has been] 
banging on about getting myself sorted and off 
the drugs….It’s taken a while and I’m in the right 
place to move forward for once, no more gear – 
nothing. I’m done with that life….I’m clean now 
with no intention of using, so why do I need this?”  
                [Male prisoner] 
Negative and confused range of 
perceptions 
 Induction sub-optimal  
No systematic way for tracking key segments 
of prisoners (“churn” issues) 
Use of “clinics” to reinforce key messages 
 Leaflet drops limited value 
 Post-release period key 
Identification and Engagement of 
Prisoners 
“Training [is] good and I’m glad I have done it, a real 
eye opener a lot of stuff I didn’t know. I know a lot of 
the lads think that ‘cos they [are not] using in jail they 
don’t think they need it but that’s not the case on the 
out. Best to get them…when they hit the hostels and 
it’s [drugs] around them again when they might be 
tempted [to use].                
      [Male prisoner] 
Identification and Engagement of 
Prisoners 
At the time of the study, distribution effected 
by Patient Group Directives 
 Staff fear use for illicit means (e.g. through use 
of the needle) 
 Prisons had different internal systems to place 
THN with prisoners (use of “props” or “vals”)  
Realities of Distribution within 
Prison Settings 
Addressing Stakeholder Perceptions 
 Provide literature (Q&A) and discussions with 
prisoners to allay concerns 
Identification and Engagement of Prisoners 
 Consider mandatory training for all opiate users  
 Integrate THN within life skills training  
Possible Service Enhancements 
Identification and Engagement of Prisoners 
 “Clinics” to reinforce knowledge 
 Consider MI to track prisoners within prison 
and with community services  
 Integrate THN within Routes to Recovery maps 
 Foll0w-up training post-release (e.g. hostels) 
Possible Service Enhancements 
Distribution of THN in Prison Settings 
 Process map final distribution point (e.g. props 
or vals)  
 Consider role for non-clinical teams including 
peers in the distribution chain 
 Ensure senior management buy-in and 
encourage wider staff awareness of THN 
Possible Service Enhancements 
 Paper published in Harm Reduction journal 
www.harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-
0094-1 
 Forthcoming short paper in Drug and Alcohol 
Today 
 Contact details: arun.sondhi@therapeutic-solutions.org.uk 
 
 
Thank You! 
  
Tramspotting: Blackpool’s story 
 
Jacqueline Reynolds, Lead Nurse, Substance Misuse, Delphi Medical 
Nicki Da Costa, Naloxone Trainer, Drugline Lancashire Ltd 
Tramspotting – A Blackpool 
Perspective of Naloxone 
Jackie Reynolds – Lead Nurse Delphi Medical 
&  
Nicki Da Costa – Lead Trainer Drugline Lancashire Ltd 
 
 
A Blackpool overview 
Myth or fact? 
When to administer 
How to administer 
Naloxone 
Large injecting population 
Poly drug and alcohol users 
Drug using homeless cohort 
Transient population 
Blackpool – An Overview 
Where do we issue Naloxone? 
Where do we issue Naloxone? 
Where do we issue Naloxone? 
 https://www.youtube.com/watch?v=zv29rQayocM 
 
 The full clip from Pulp Fiction is available on the 
following link: 
 https://youtu.be/jpMxpzfSRUA 
 
Myth! 
 https://www.youtube.com/watch?v=_A_1qroHxW8 
Fact! 
Can be issued anywhere 
Easy to administer 
Simple to train  
Can be used by anyone 
 
 
Fact 
 Since May 2015 we have issued approximately 380 
Naloxone kits  
 8 reported uses – although we suspect this figure will 
be higher 
The story so far….. 
A thank you …… 
And another … 
 ndacosta@druglinelancs.co.uk 
 jacqueline.reynolds@delphimedical.co.uk 
 
Thank you! 
  
The complex question of drug related deaths. No 
simple answer 
 
Liz McCoy, Directorate Manager, Drugs and Alcohol, Pennine Care NHS 
Foundation Trust 
• Spike in drug related deaths 
• Unclear picture as to cause 
• Some ideological positions being adopted 
• Emerging picture in operational services noted by front line 
staff and managers. 
 
 
 
                     Background 
        Initial Study-Lines of Enquiry 
• Analyse of all Pennine Care footprint deaths for 2013 
undertaken 
• Examination of : 
– Incident reports 
– Coroners reports 
– Case files 
• 33 cases examined-21 identified as primary drug clients 
• Wide variety of possible  variables considered (27) 
  Findings – Lines of Enquiry Study 
                          What we didn’t find….. 
• Is it alcohol? 
– 50% were not alcohol users 
• Is it age? 
– Youngest 28 years , oldest 57. Most 30’s and 40’s.  
• Is it service transfer/disruption? 
– No increase before or after service transfer (both in and out of service) 
• Is it liberal prescribing? 
– Wide range of prescribing interventions, some not prescribed 
• Is it abstinence focused regimes? 
– No time limited treatment, no compulsory detox 
 
                  So, who is it? 
 • Multiple and complex needs-mental health, personal 
vulnerability, self neglect, 
• Hard to engage and sometimes chaotic 
• Well known to services- easily recognised even from 
‘anonymised’ information 
                                   and, 
                           significantly… 
        Compromised physical health  
            (Causal, contributory and present) 
 
 
                   Extended Study 
• Examined all drug related deaths across the Trust for the 
last 5 years ( up until August 2015) 
• Identified 199 drug deaths (further 103 alcohol deaths) 
• Focused examination of: 
– Causes of death 
– Circumstances at or immediately prior to death 
 
Grouped into 6 broad categories to make complex data 
manageable ( by themes). 
 
     Extended study- Initial Findings 
• Overdoses or possible overdoses 
               10 % 
• Accidents ( Inc RTAs etc.) 
                  6% 
• Suicides  
                  6%     
        (12 in all of which 10 were hangings- 5 of them in a 4 month period) 
 
• Homicides  
                    1% (n2)  
 
 
 
   Extended Study – Initial Findings 
• Unclear Cause of Death 
                    28% 
      Including…. 
  Found under a Bridge, open verdicts, misadventure (not stated as    
overdose) , transferred out clients, found by the police and CoD not provided 
to Trust by GP or coroner.  
 
Need to obtain further information to establish outcome. 
 
Likely to be a combination of other fields. 
 
  
    Extended Study- Initial Findings 
• Physical Health (as sole, main or most significant issue) 
 
 
                            48% 
 
Includes :- 
      Expected deaths, Died in hospital, died at home, died in public 
places, taken into hospital as emergency admission. 
     Extended Study- Initial Findings  
                    Physical Health- Main Causes 
• Any respiratory and circulatory (single cause)   28.5% 
 
• Any GI ( inc alcohol indicators)                          21% 
 
•  Any Cancer                                                       12.5% 
 
• Multiple Factors                                                  38%  
  
 
      Extended Study-Initial Findings  
                          Multiple Factors 
Including: 
         Multiple organ failure 
         Brain cyst 
         Cardiac with other factors 
         HIV  
        ‘Chronic Illness’ 
         COPD and Hep C 
      Etc…………. 
 
      Extended Study- Initial Findings 
• Physical Health  
 
– Undefined and unidentified 
 
– Unmanaged ( by client and professionals) 
 
– Self neglect and ‘careless’  with health 
 
– Multiple and complex presenting  issues 
                    Next Steps 
• Re-examine existing information including by independent  peers 
• Examine case notes for Extended Study 
• Obtain missing and additional data ( GP/ Coroner ) 
• Undertake full academic study (possibly using variables from 
pilot) 
 
      Develop service response  
 
                    Health Warning 
• Not an academic study ( but have tried hard to keep data 
clean) 
• Some judgement and subjectivity due to complex and 
imprecise  nature of source information 
• Has not been peer reviewed  
                              However 
• Has ‘real world’ validity- (ask your front line staff) 
• Provides good basis for service responses 
• Trend seems to be continuing- 5 recent physical health deaths.  
 
 
 
         
           Thank You. 
  
Seasonal influenza vaccination: A pilot programme 
aimed at improving uptake in drug users 
 
Sally Morrison-Griffiths, Associate Medical Director, Addaction 
People who use drugs may be at higher risk of 
developing complications of influenza due to a 
number of reasons: 
 Ageing cohort 
 Diagnosed & undiagnosed chronic conditions 
 Poor nutrition and general health neglect 
 Homelessness, unemployment and poverty 
 Some may be less likely to visit GP 
 
 
 Concern about deaths among service users 
from bronchopneumonia 
 
 Addaction St Helens were approached by NHS 
England, Merseyside Area Team & PHE 
 
 ‘Out of Practice’ Service Specification 
 
 
 
 Seasonal Influenza Immunisation 
Programme Outside General Practice 
 To improve access to the seasonal 
influenza vaccine 
 A clear, robust clinical pathway 
 1st October 2014 – 31st March 2015 
 Review date 1st April 2015 
  Population = 176,000 
 
 Addaction is the sole provider of alcohol 
and drug services in St Helens 
 
 Over 500 individuals on a prescription for 
methadone or buprenorphine 
 
 
 
February 2014 
 
 503 service users on an opioid substitution 
therapy (OST) prescription 
 
 Audit of 185 casenotes (37%) 
 
 97 individuals (52%) diagnosed with one or 
more long-term conditions on the GP summary 
 A number of meetings 
 A Patient Group Direction (PGD) 
 Signed up to the service 
 Leaflets and posters 
 Confirmation of cold chain 
 Training update for nurses & doctors 
 An evaluation at the end of pilot scheme 
 First vaccinations 28th October 2014 
 28th October 2015 – 31st March 2016 
 Opiate users on a script = 515 
 Offered = 340 (66%) 
 Declined = 106 (31%) 
 Already had = 29 (9%) 
 Accepted = 205 (60%) 
Chronic Disease Number 
Liver 54 
Respiratory 50 (COPD = 26  Asthma = 24) 
Ischaemic Heart Disease 4 
Kidney Disease 2 
Cancer 2 
Type I DM 1 
Stroke 1 
HIV 1 
Other 95 
  April 2015 
 60 questionnaires 
 51 respondents 
 For the question “Do you think it is a positive 
thing that Addaction offered the flu jab?” 
 44 (86%) = yes 
  6 (12%) = not sure 
  1 (2%) = no 
 Seasonal Influenza Vaccination can be 
safely and effectively administered 
outside General Practice to improve 
uptake in a population of high 
morbidity, high mortality and high 
deprivation index. 
sally.morrison@addaction.org.uk 
 
  
A review into drug-related deaths in Cumbria 
 
Paul Musgrave, Senior Manager, Cumbria County Council 
Serving the people of Cumbria 
Do not use fonts other than Arial for your presentations 
Drug Poisoning Deaths 
Defined by the Office of National Statistics according to 
a set of international classification of disease  
codes. This is an overarching category including deaths 
caused by over-the-counter, prescription and illicit 
drugs. Drug misuse deaths are a subset of drug 
poisoning deaths.  
Serving the people of Cumbria 
Do not use fonts other than Arial for your presentations 
Overview 
• The rate of drug poisoning mortality in Cumbria 
increased between 2008-10 and 2012-14 from 5.3 to 
7.7 deaths per 100 000 population (not a significant 
increase).  
• Carlisle has the highest rate of death related to drug 
poisoning.  
• There is an increasing trend of drug poisoning 
mortality in North Cumbria.  
• In 2014, 74% of drug poisoning deaths were related 
to drug misuse, and during the review period of 2012-
2014 64% of drug poisoning deaths were due to drug 
misuse.  
Serving the people of Cumbria 
Do not use fonts other than Arial for your presentations 
Socio demographic profile 
• Carlisle had a significantly higher rate of drug 
poisoning mortality in 2012-14 compared to other 
areas and Cumbria as a whole.  
• Those who died as a result of drug poisoning were 
predominantly male (on average 70%).  
• There is a clear association with deprivation; those 
living in the most deprived communities have a 
significantly higher rate of drug poisoning mortality.  
• On average 1,097 potential years of life were lost 
(PYLL) each year.  
Serving the people of Cumbria 
Do not use fonts other than Arial for your presentations 
Profile continued 
• The average age of death was 41 years.  
• Male drug poisoning mortality peaked in the 35-44 
age range.  
• Female drug poisoning mortality peaked in the 25-34 
age range,.  
• Leaving school at age 16 or before, being 
unemployed, single, and living alone were common 
characteristics among those who died.  
• 56% of those who died had at least one child and as 
a result 109 children lost a biological parent due to a 
drug poisoning death between 2012 and 2014  
 
Serving the people of Cumbria 
Do not use fonts other than Arial for your presentations 
Significant life events 
• 6% of those who died had previously been a looked 
after child.  
• 20% had experienced childhood abuse (emotional, 
physical, or sexual).  
• 11% had been a victim of domestic abuse (all were 
female).  
• 26% had attempted suicide in the past; females were 
more likely than males to have attempted suicide. 
Serving the people of Cumbria 
Do not use fonts other than Arial for your presentations 
Coroner verdicts 
• For 26% of deaths a verdict of ‘misadventure’ was 
delivered.  
• 20% had a narrative verdict.  
• 16% had a verdict of either ‘suicide’, or an ‘open’ 
verdict.  
• A verdict of ‘abuse of drugs’ was more likely to be 
delivered in South and East Cumbria.  
• A verdict of ‘drug related’ was more likely to be 
delivered in North and West Cumbria.  
Serving the people of Cumbria 
Do not use fonts other than Arial for your presentations 
Toxicology 
• Toxicology data was viewed for 40 deaths (41% of the sample).  
• Antidepressants were the most common drug present at the time 
of death (53%) and implicated in death (30%).  
• Diazepam was the second most common drug present at the time 
of death (48%) and implicated in death (23%).  
• Diazepam and alcohol was the most common combination of 
illicit drugs present at the time of death (13%).  
• Alcohol was found in the system at the time of death in 48% of 
cases with toxicology data;  the average blood alcohol level was 
153 mg/ml (i.e. almost 2 times the UK level driving limit of 80 
mg/ml). 
Serving the people of Cumbria 
Do not use fonts other than Arial for your presentations 
Drug use history 
• 61% of individuals were known to have been a drug user 
at some point in their life (75% of males and 30% of 
females).  
• Of the known drug users, 63% used heroin, 53% had 
alcohol problems, and 17% abused benzodiazepines.  
• Of the known drug users, 75% were poly drug users and 
38% had used drugs intravenously.  
• The average age of first illicit drug use was 15 years.  
• The average age of first alcohol use was 14 years.  
• Of the 98 drug poisoning deaths, 48% were known to 
have experienced a previous non-fatal overdose.  
Serving the people of Cumbria 
Do not use fonts other than Arial for your presentations 
Medical conditions 
• 77% had at least one mental health diagnosis, most 
commonly depression (54%).  
• 18% had a dual diagnosis.  
• 62% had at least one physical health condition, most 
commonly diseases of the nervous system (25%).  
• 16% had chronic pain.  
• 9% had a diagnosis of hepatitis C.  
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Contact with services 
• 78% of individuals were known to the police through their intelligence 
system.   
• 60% were seen in custody in the last 6 years, 37% in the 12 months 
before death.  
• 34% were known to have spent time previously in prison at some point 
in their life.  
• 79% had seen their GP in the year prior to their death, with 54% of 
these consulting at least in part for either a mental health or drug 
related problem. 47% saw their GP in the month before they died and 
20% saw their GP in the last week of their life.  
• 56% had some contact with specialist mental health services in their 
lifetime, 34% had contact in the 12 months before death and 10% had 
contact in the week before death.  
• 18% were active clients with specialist mental health services at the 
time of death.  
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Contact with services 
• Overall 37% were known to have had some contact with substance 
misuse recovery services in Cumbria in their lifetime. This is in the 
context of 64% of the deaths in the sample being ascribed to drug 
misuse, as well as 61% of those who died having been known to be a 
drug user at some point in their lives.  
• Of those in contact with drug services, 5 (18%) were seen in the last 
week of their life. Of the total number who died 22% were seen in the 
12 months before death by drug services, with 5% being seen in the 
week before death.  
• Of the 13 individuals who were active with substance misuse recovery 
services at the time of death, 10 were prescribed a substitute drug 
when they died.  
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Methadone and heroin/morphine related deaths 
• Of the 98 drug poisoning deaths, 21% were methadone related.  
• Over the last 7 years, methadone related deaths in Cumbria have on 
the whole followed an increasing trend.  
• For methadone related deaths the average age was 36 years and the 
highest proportion lived in Barrow 
• Of the 21 people who died as a result of a methadone related death, 
only 6 (29%) were receiving a methadone prescription at the time of 
death.  
• Of the 98 drug poisoning deaths, 17% were heroin/morphine related, 
and of these only 12% were on a substitute prescription at the time of 
death.  
• The trend of heroin/morphine related deaths over the last 7 years has 
been sporadic.  
• The average age for heroin/morphine related death was 42 years and 
the highest proportion lived in Carlisle 
